Clinical trial
Nabilone for Non-motor Symptoms in Parkinson's Disease: An Open-label Study to Evaluate Long-term Safety and Efficacy
NCT03773796 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nabilone for Non-motor Symptoms in Parkinson's Disease: An Open-label Study to Evaluate Long-term Safety and Efficacy
- Lead sponsor
- Medical University Innsbruck
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 6, 2018
- Completion date
- January 31, 2020
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.